| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/01/2025 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 27/01/2025 | 11:45 | PR Newswire (US) | Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 23/01/2025 | 11:45 | PR Newswire (US) | Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact The Gross Law Firm | NASDAQ:APLT | Applied Therapeutics Inc |
| 21/01/2025 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality | NASDAQ:APLT | Applied Therapeutics Inc |
| 20/01/2025 | 11:45 | PR Newswire (US) | Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:APLT | Applied Therapeutics Inc |
| 16/01/2025 | 11:45 | PR Newswire (US) | The Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline | NASDAQ:APLT | Applied Therapeutics Inc |
| 13/01/2025 | 11:45 | PR Newswire (US) | Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 09/01/2025 | 11:45 | PR Newswire (US) | Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm | NASDAQ:APLT | Applied Therapeutics Inc |
| 06/01/2025 | 11:45 | PR Newswire (US) | Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 02/01/2025 | 17:48 | PR Newswire (US) | Investors in Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 02/01/2025 | 16:10 | PR Newswire (US) | Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 21/12/2024 | 02:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:APLT | Applied Therapeutics Inc |
| 20/12/2024 | 13:07 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:APLT | Applied Therapeutics Inc |
| 20/12/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Appoints John H. Johnson as Executive Chairman | NASDAQ:APLT | Applied Therapeutics Inc |
| 19/12/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT | NASDAQ:APLT | Applied Therapeutics Inc |
| 27/11/2024 | 22:10 | GlobeNewswire Inc. | Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia | NASDAQ:APLT | Applied Therapeutics Inc |
| 14/11/2024 | 23:47 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:APLT | Applied Therapeutics Inc |
| 08/11/2024 | 20:17 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:APLT | Applied Therapeutics Inc |
| 07/11/2024 | 13:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:APLT | Applied Therapeutics Inc |
| 07/11/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports Third Quarter 2024 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 05/11/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
| 18/09/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia | NASDAQ:APLT | Applied Therapeutics Inc |
| 04/09/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Participate in Upcoming Investor Conferences | NASDAQ:APLT | Applied Therapeutics Inc |
| 15/08/2024 | 00:52 | Edgar (US Regulatory) | Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] | NASDAQ:APLT | Applied Therapeutics Inc |
| 10/08/2024 | 02:43 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:APLT | Applied Therapeutics Inc |
| 07/08/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports Second Quarter 2024 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 01/07/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Added to Russell 3000® Index | NASDAQ:APLT | Applied Therapeutics Inc |
| 09/05/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports First Quarter 2024 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 07/05/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
| 15/04/2024 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer | NASDAQ:APLT | Applied Therapeutics Inc |
